<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03661749</url>
  </required_header>
  <id_info>
    <org_study_id>SLIR 2018-22</org_study_id>
    <nct_id>NCT03661749</nct_id>
  </id_info>
  <brief_title>Urinary Protein to Creatinine Ratio in Term Pregnant Women</brief_title>
  <official_title>Urinary Protein to Creatinine Ratio in Term Pregnant Women: What is the Effect of a Clean Catch Urine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Luke's Hospital, Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Luke's Hospital, Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine the incidence of elevated U Pr/Cr in normal term pregnant women. In
      addition we will determine if a &quot;clean catch&quot; urine has an effect on the U Pr/Cr.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clean catch urine should be used due to possible vaginal secretion contamination with falsely
      elevated U Pr/Cr ratio. However, no supporting reference was found in the article and no
      control group with random urine collection for comparison to clean catch specimen U Pr/Cr was
      included in their study. The original studies that validated spot Pr/Cr urine as a predictor
      of 24 -hour total urine protein used random non-clean catch random urines . They had an r
      value of .93-.99 in estimating total protein excreted in 24 hours. At our institution we use
      Siemens-base test to determine U Pr/Cr. In the product insert the company states that no
      special patient preparation is necessary.

      Thus, this study will determine the incidence of elevated U Pr/Cr in normal term pregnant
      women. In addition we will determine if a &quot;clean catch&quot; urine has an effect on the U Pr/Cr.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2018</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>PR/CR urine collected by clean catch or non -clean catch technique will be compared in term pregnancy</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>elevated PR/CR ratio using clean catch technique</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>this will be the proportion of patients with PR/CR ratio greater than or equal to 0.3 in urine using a clean catch method.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Report the incident of PR/CR ratio greater than 0.3</measure>
    <time_frame>through study completion, average of 1 year</time_frame>
    <description>overall incident of elevated PR/CR ratio in healthy term pregnant women</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Pregnancy Complications</condition>
  <arm_group>
    <arm_group_label>Clean catch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>women in this group will collect urine for PR/CR using a clean catch technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-clean catch</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>women in this group will not employ clean catch technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>clean catch</intervention_name>
    <description>clean catch technique applied to collect urine for PR/CR ratio</description>
    <arm_group_label>Clean catch</arm_group_label>
    <arm_group_label>Non-clean catch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women of 37 weeks gestation or greater

        Exclusion Criteria:

          -  Urinary tract infections

          -  Hypertension

          -  Pre-eclampsia

          -  Renal dysfunction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant females 37 weeks gestation or greater</gender_description>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James N Anasti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Luke's University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James N Anasti, MD</last_name>
    <phone>484-526-8878</phone>
    <email>anastij@slhn.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>St Luke's University Hospital</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 31, 2018</study_first_submitted>
  <study_first_submitted_qc>September 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2018</study_first_posted>
  <last_update_submitted>September 6, 2018</last_update_submitted>
  <last_update_submitted_qc>September 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Luke's Hospital, Pennsylvania</investigator_affiliation>
    <investigator_full_name>James Anasti, MD</investigator_full_name>
    <investigator_title>Clinical Professor of OB/GYN</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

